Resultados da busca - H.T. Eich
- Mostrando 1 - 6 resultados de 6
-
1
Updated strategies in the treatment of benign diseases—a patterns of care study of the german cooperative group on benign diseases por Jan Kříž, Heinrich Seegenschmiedt, Amelie Bartels, Oliver Micke, Ralph Muecke, U. W. Schaefer, Uwe Haverkamp, H.T. Eich
Publicado em 2018Artigo -
2
Multicenter, Phase III Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology por Ralph Muecke, Oliver Micke, Lutz Schomburg, Michael Glatzel, Berthold Reichl, Klaus Kisters, U. W. Schaefer, Jutta Huebner, H.T. Eich, Khashayar Fakhrian, Irenäus A. Adamietz, Jens Buentzel
Publicado em 2014Artigo -
3
Correlation Between Progression-Free and Overall Survival in Patients with Hodgkin Lymphoma: A Comprehensive Analysis of Individual Patient Data from Randomized GHSG Trials por Paul J. Bröckelmann, Horst Müller, Michael Fuchs, Silke Gillessen, Dennis A. Eichenauer, Sven Borchmann, Anne Sophie Jacob, Karolin Behringer, Jesko Momotow, Justin Ferdinandus, Boris Böll, Xiaoqin Yang, Carsten Kobe, H.T. Eich, Christian Baues, Wolfram Klapper, Andreas Engert, P. Borchmann, Bastian von Tresckow
Publicado em 2024Artigo -
4
Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients por Markus Hecht, Lisa Zimmer, Carmen Loquai, Carsten Weishaupt, Ralf Gutzmer, Barbara Schuster, S. Gleisner, B. Schulze, Simone M. Goldinger, Carola Berking, Andrea Forschner, Patrick Clemens, Gerhard G. Grabenbauer, Tina Müller-Brenne, Julia Bauch, H.T. Eich, Stephan Grabbe, Dirk Schadendorf, Gerold Schuler, Petra Keikavoussi, Sabine Semrau, Rainer Fietkau, Luitpold Distel, Lucie Heinzerling
Publicado em 2015Artigo -
5
Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT por Juliane Hörner‐Rieber, Denise Bernhardt, Oliver Blanck, Marciana Nona Duma, H.T. Eich, S. Gerum, Eleni Gkika, Peter Hass, Christoph Henkenberens, Hans‐Ulrich Herold, Guido Hildebrandt, Detlef Imhoff, Klaus-Henning Kahl, Stefan Janssen, K. Jurianz, R. Krempien, Stefan Lautenschläger, Fabian Lohaus, Arndt-Christian Mueller, Cordula Petersen, I. Sackerer, Davide Scafa, E. Schrade, Lorenz Uhlmann, Andrea Wittig, Matthias Gückenberger
Publicado em 2019Artigo -
6
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus por Christian Buske, Martin Dreyling, Alberto Álvarez‐Larrán, J. Apperley, Luca Arcaini, Caroline Besson, Lars Bullinger, Paolo Corradini, Matteo Giovanni Della Porta, Meletios Α. Dimopoulos, Shirley D’Sa, H.T. Eich, R. Foà, Paolo Ghia, María Gomes da Silva, John G. Gribben, Roman Hájek, Conrad Harrison, M. Heuser, Barbara Kiesewetter, Jean‐Jacques Kiladjian, Nicolaus Kröger, P. Moreau, Jakob Passweg, Flora Peyvandi, Delphine Réa, Josep‐María Ribera, Tadeusz Robak, Jesús F. San Miguel, Valeria Santini, Guillermo Sanz, Pieter Sonneveld, Marie von Lilienfeld‐Toal, Clemens‐Martin Wendtner, George Pentheroudakis, Francesco Passamonti
Publicado em 2022Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Oncology
Radiation therapy
Randomized controlled trial
Surgery
2019-20 coronavirus outbreak
Adjuvant
Adjuvant therapy
Cancer
Cancer research
Cervical cancer
Concomitant
Consensus conference
Coronavirus disease 2019 (COVID-19)
Correlation
Dabrafenib
Dermatology
Diarrhea
Disease
Family medicine
Gastroenterology
Geometry
Hodgkin lymphoma
Infectious disease (medical specialty)
Intensive care medicine
Law
Lung
Lung cancer
Lymphoma